SEC Form 4 · accession 0001127602-15-011296
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Officer — EVP & Chief Operating Officer
Period of report
Jan 2, 2015
Accepted (ET)
Mar 13, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,153 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF2 | $127.73 | Jan 2, 2015 | A | 37,500 | A | Jan 2, 2016 | Jan 2, 2025 | Common Stock | 37,500 | 37,500 | D |
Explanation of responses
- F1Includes 222 shares acquired under the United Therapeutics Corporation Employee Stock Purchase Plan on March 4, 2015.
- F2These share tracking awards vest in one-fourth increments on each of January 2, 2016, 2017, 2018 and 2019, and settle in cash only.